RecruitingPhase 4NCT07045155

Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese PLA General Hospital
Principal Investigator
Xiangmei Chen
Chinese PLA General Hospital
Intervention
The rHuEPO Monotherapy Group (Control Group)(drug)
Enrollment
240 enrolled
Eligibility
18-80 years · All sexes
Timeline
20252028

Study locations (1)

Collaborators

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07045155 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials